FinnMedi Oy: Clinical Trials

4 trials sponsored by FinnMedi Oy, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 1 suspended, 1 unknown. 1 Not applicable, 1 Phase 1, 1 Phase 4.

By phase and status

PhaseTrialsStatus
Not applicable1Suspended 1
Phase 11Completed 1
Phase 41Completed 1

Follow FinnMedi Oy: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Food Challenge With Barley Starch as Active Comparator
Barley starch, Maize starch - Allergy;Food, Allergy Wheat
Not applicableSuspendedLyckeby Starch AB402017-10-132019-03-05
Evaluation of Long-term HPV Vaccine Efficacy
Screening for cervical cancer - Uterine Cervical Cancer
UnknownTampere University100002011-05-012014-05-15
The Effects of Preservative-free Prostaglandin Eye Drops in Sign and Symptoms on the Eyes of Patients With Glaucoma
Tafluprost 0.0015% - Ocular Hypertension, Open-Angle Glaucoma
Phase 4CompletedFinnMedi Oy302010-08-012014-10-28
Cis-urocanic Acid (Cis-UCA) in Patients With Primary or Recurrent Non-muscle Invasive Bladder Cancer
cis-UCA solution - Non-muscle Invasive Bladder Cancer
Phase 1CompletedBioCis Pharma Ltd122009-10-012012-11-12

Conditions studied

Food Hypersensitivity (1)  ·  Glaucoma, Open-Angle (1)  ·  Non-Muscle Invasive Bladder Neoplasms (1)  ·  Ocular Hypertension (1)  ·  Recurrence (1)  ·  Urinary Bladder Neoplasms (1)  ·  Uterine Cervical Neoplasms (1)  ·  Wheat Hypersensitivity (1)

Interventions

Mass Screening (1)  ·  Starch (1)  ·  tafluprost (1)

Countries

Finland (4)

Top investigators

Hannu Uusitalo, MD, PhD (1)  ·  Juha Peltonen, MD (1)  ·  Marita Paassilta, MD, Docent (1)  ·  Matti Lehtinen, M.D., Ph.D. (1)

NIH funding

2009 (1)